Autolus Therapeutics (AUTL) Change in Account Payables (2018 - 2025)

Autolus Therapeutics' Change in Account Payables history spans 5 years, with the latest figure at -$7.5 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 2370.69% year-over-year to -$7.5 million; the TTM value through Dec 2025 reached $1.3 million, down 18.24%, while the annual FY2025 figure was $1.3 million, 18.24% down from the prior year.
  • Change in Account Payables reached -$7.5 million in Q4 2025 per AUTL's latest filing, down from $5.4 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $5.4 million in Q3 2025 to a low of -$7.5 million in Q4 2025.
  • Average Change in Account Payables over 4 years is $191538.5, with a median of $276000.0 recorded in 2024.
  • The largest YoY upside for Change in Account Payables was 1864.13% in 2025 against a maximum downside of 2370.69% in 2025.
  • A 4-year view of Change in Account Payables shows it stood at $109000.0 in 2022, then plummeted by 630.28% to -$578000.0 in 2023, then soared by 157.27% to $331000.0 in 2024, then tumbled by 2370.69% to -$7.5 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Change in Account Payables are -$7.5 million (Q4 2025), $5.4 million (Q3 2025), and $1.5 million (Q2 2025).